WHO ICTRP trial
Impact of pharmaceutical care on the health outcomes in patients with systemic…
RBR-10j7gj5w · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Not Recruiting
Key facts
| Trial ID | RBR-10j7gj5w |
|---|---|
| Public title | Impact of pharmaceutical care on the health outcomes in patients with systemic arterial hypertension and different care needs: a randomized controlled trial |
| Scientific title | Validation of patient selection indicators for insertion in a pharmaceutical care service focused on primary care |
| Primary sponsor | Faculdade de Ciências Farmacêuticas de Ribeirão Preto |
| Secondary sponsors | Faculdade de Ciências Farmacêuticas de Ribeirão Preto |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Not Recruiting |
| Study type | Intervention |
| Countries | Brazil |
| Conditions | Essential (primary) hypertension; Hypertension;I10-I15 |
| Interventions | Experimental Group (35 patients): Patients received pharmaceutical care (pharmacotherapy review, pharmacotherapeutic follow-up), health education, for a period of 12 months. Control Group (34 patients): Received only health education for a… |
| Registration date | Jan 3, 2021 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: